Contents related with AMD
Dr. Jordi Monés explains at LIGHT 2017 the new hypothesis in geographic atrophy developed by the BMF
The BJO publishes a new classification of geographic atrophy subtypes identified by BMF researchers
Dr Monés: «Gene therapy will evolve quicker than cell therapy for the treatment of atrophic AMD»
Geographic atrophy phenotype identification by cluster analysis
A cluster analysis and an animal model of geographic atrophy, the features of BMF’s contribution to EURETINA 2017
The new hypothesis on the progression of AMD to GA at Maculart
Stem cells, biomarkers and microbiome in the limelight at the Board of Trustees meeting
EYE-RISK debates genetic tests for AMD at ARVO 2017
Drusen Ooze: A Novel Hypothesis in Geographic Atrophy
ADVANCE(CAT) - Accelerator for the development of advance therapies in Catalonia (Official Code: COMRDI15-1-0013)
Atrophy models that makes it possible to work with regenerative therapies on near-real examples
Research is the only solution for the future to fight against blindness
It is only with your help that we can fight against blindness
Collaborate